Juniper Pharmaceuticals, Inc. (NASDAQ:CBRX)

CAPS Rating: 2 out of 5

The Company is engaged in the research, development, and commercialization of women's healthcare and endocrinology products, including those that treat and are intended to treat infertility, endometriosis, dysmenorrhea and hormonal deficiencies.

Caps

How do you think CBRX will perform against the market?

Add Stock to CAPS Watchlist

All Players

68 Outperform
12 Underperform
 

All-Star Players

6 Outperform
9 Underperform
 

Wall Street

3 Outperform
0 Underperform
 

Top CBRX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

figglebird (49.48)
Submitted April 15, 2012

Odds are better than blackjack... substantially...

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CBRX VS S&P 500 (SPY)

Fools bullish on CBRX are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about CBRX.

Recs

1
Member Avatar figglebird (49.48) Submitted: 4/14/2012 8:52:31 PM : Outperform Start Price: $5.48 CBRX Score: -51.03

Odds are better than blackjack... substantially...

Recs

1
Member Avatar rinchenmtp (< 20) Submitted: 8/9/2011 3:45:48 PM : Outperform Start Price: $19.76 CBRX Score: -138.13

CBRX will get FDA approval for its PROCHIEVE® Vaginal Progesterone Gel by the end of February. Watson must pay CBRX a $5,000,000 milestone payment and will sell the drug.

Prochieve will allow women with short cervix's a 90% chance of bringing their pregnancy to term. As opposed to overwhelming amount of pre-mature births for women with cervical lengths of 2.5cm and smaller.

Also, I believe that Prochieve will be used on all woman regardless of the cervical length given the litigious problems for Dr's in the maternity field.

I see a target price of around $5-$7 around Feb. 2012.

Worst case scenario, CBRX gets bought by Watson.

Recs

1
Member Avatar XMFAllumbrado (< 20) Submitted: 7/27/2011 10:47:46 PM : Outperform Start Price: $23.44 CBRX Score: -164.21

By Feb 2012 the FDA should approve the progesterone gel that will prevent premature births for women with small cervix's. I believe that it will become a standard practice to use on all pregnant women. Dr.'s do not want to get sued, and insurance companies will pay.

Leaderboard

Find the members with the highest scoring picks in CBRX.

Score Leader

schwah5

schwah5 (93.70) Score: +184.95

The Score Leader is the player with the highest score across all their picks in CBRX.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
schwah5 93.70 7/30/2008 Underperform NS $32.64 -77.45% +107.50% +184.95 0 Comment
JackOffBadApples 89.80 9/12/2008 Underperform 3W $26.16 -71.87% +112.04% +183.90 0 Comment
ScreenerStizBear 41.55 6/26/2008 Underperform NS $27.44 -73.18% +104.51% +177.69 1 Comment
SwMad 90.08 1/3/2007 Underperform 3W $40.88 -82.00% +90.62% +172.62 0 Comment
cecamadocv4 99.95 12/22/2010 Underperform 5Y $17.04 -56.81% +103.46% +160.26 0 Comment
Maribaza 96.78 12/16/2010 Underperform 5Y $14.88 -50.54% +104.87% +155.41 1 Comment
hmarkguy 81.72 5/15/2007 Underperform 5Y $18.31 -59.80% +78.67% +138.47 0 Comment
BDK34 91.19 5/22/2007 Underperform 3Y $19.12 -61.51% +76.88% +138.38 0 Comment
raisethesky < 20 9/26/2007 Underperform NS $19.36 -61.98% +75.80% +137.79 0 Comment
RafaelStockNegat 97.11 8/5/2010 Underperform 5Y $7.76 -5.15% +126.75% +131.91 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackTheBenchmar 81.30 10/5/2010 Outperform NS $8.96 -17.86% +122.53% -140.39 0 Comment
TrackRodmanRen < 20 8/8/2008 Outperform NS $30.64 -75.98% +108.26% -184.24 0 Comment
TrackCarisandCo 90.98 5/28/2008 Outperform NS $30.80 -76.10% +90.59% -166.70 0 Comment

Featured Broker Partners